Plasma torque teno virus (TTV) DNA load directly correlates with the degree of T‐cell
immune reconstitution early after allogeneic hematopoietic stem cell transplantation (allo …

Abstract Background Torque Teno virus (TTV) plasma DNA load directly correlate with the
level of immunosuppresion in different clinical settings. It is uncertain whether this may be …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established treatment
option for several hematological diseases. However, the first year post-transplantation is …

Background Several reports have proposed that the viral load of torque teno virus (TTV) in
plasma is a biomarker of immune function in solid organ transplantation (SOT) and in …

Torque teno virus (TTV) plasma DNA load has been consistently shown to be a surrogate
biomarker of immunosuppression in solid organ transplant recipients. It is uncertain whether …

Abstract Torque Teno virus (TTV) DNA load in blood may act as a marker of immune
competence after allogeneic hematopoietic stem cell transplant recipients (allo‐HSCT) …

Torque teno virus (TTV) has been proposed as a surrogate biomarker of T-cell function in
allogeneic–haematopoietic–stem-cell transplantation (allo-HSCT). Conflicting data exists …

Torque teno virus (TTV) is a nonenveloped, single-stranded, circular DNA virus of the family
of Anelloviridae. The first contact with TTV usually occurs in early childhood, followed by …

Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for
hematological malignancies are at high risk of infections. 1 The synergy of transplant …

Background. Lung transplantation is the only therapeutic option in end-stage lung diseases;
however, survival after transplantation is limited by acute and chronic rejection or infectious …